Bras, girdles and leggings infused with caffeine and sold as weight loss aids are being recalled by the FTC.» Read More
The federal government says 10.3 million adults have become newly insured since the launch of Obamacare last fall.
Roche confirmed its full-year outlook, but posted profit that missed expectations following an impairment charge at its diagnostics business.
Gilead Sciences delivered quarterly earnings and revenue that topped analysts' expectations on Wednesday.
When Senate Majority Leader Harry Reid went "nuclear" last winter, he just might have saved a major part of Obamacare from a huge challenge it faces.
The GAO said that 11 out of 12 fictitious applicants secured government subsidized healthcare. NBC News reports.
U.S. generic drug rules have been manipulated by brand-name drug companies to keep cheaper competition off the market, a report says.
After a split ruling on Obamacare from the courts, who gets the last word? Law professor Dan Eaton weighs in.
Puma Biotechnology's experimental breast cancer drug met its main goal in a late-stage trial, but the options market is sensing something funky.
In a dramatic split decision, two federal appellate panels disagreed on the legality of billions of dollars in government subsidies for Obamacare.
GlaxoSmithKline's share price plunged immediately following the announcement of its second quarter results on Tuesday.
These are the complete texts of today's decisions by two U.S. appeals courts on whether subsidies provided under Obamacare are illegal.
Bill Ackman fired his latest shot at Herbalife Tuesday, but the company's stock mostly rose during the investor's presentation.
The intellectual godfather of a major Obamacare court challenge says it could "free" tens of millions of people from the law's mandates.
A separate US appeals court upheld a federal regulations that implemented subsidies that are vital to President Obama's healthcare overhaul.
Allergan on Monday said that its second-quarter profit and sales rose, and it announced $475 million in cost cuts.
Valeant has complained to regulators that claims made by Allergan to counter a hostile takeover are misleading, sources have told CNBC.
A decision by a Florida jury to impose damages of $23.6 billion against RJ Reynolds is likely to be rejected or reduced on appeal, experts say.
FedEx's indictment for shipping packages from illegal online pharmacies isn't hurting shares, which makes sense to one analyst.
Several court challenges to a key part of Obamacare could lead to average premium increases of 76 percent for subsidized HealthCare.gov enrollees.
U.S. drugmaker announces plans to take over Dublin-based Shire in a deal that will help AbbVie lower its tax rate by buying a foreign rival.
Get the best of CNBC in your inbox